openPR Logo
Press release

Somatostatin Analogue Drug Market Trends, Growth, Analysis and Forecast - 2025

08-08-2020 02:04 PM CET | Health & Medicine

Press release from: Orion Market Research

Somatostatin Analogue Drug Market

Somatostatin Analogue Drug Market

The global somatostatin analogue drug market is anticipated to showcase considerable growth during the forecast period (2020-2026). The rising FDA approvals, advancement in new treatment therapies, and new product launches are some of the key factors contributing to the growth of the hormone therapy replacement therapy market across the globe. According to the American Cancer Society, there are around 5,000 new carcinoid tumors diagnosed in the US each year. According to the National Center for Biotechnology Information, 1 million cases of neuroendocrine tumors (NET) occur every year across the globe which is expected to get increased in the future due to the high adoption of sedentary lifestyles. The NET is found to have low incidence and high prevalence, the high prevalence of NET. The rapid diagnosis of the NET disorder enhances the adoption rate of the drugs for the treatment of the disease, thereby promoting the growth of the somatostatin analogue drug market across the globe.

Get Sample Copy of Somatostatin Analogue Drug Market at:

Top Key Players - Camurus AB, Chiasma, Inc., Ipsen Group, Boehringer Ingelheim International GmbH, Eli Lilly & Co., F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Tarveda Therapeutics Inc., Teva Pharmaceutical Industries Ltd.

so, on are the prominent players operating in the somatostatin analog drug across the globe. The major players of the somatostatin analogue drug market are making hefty investments in the R&D of new drugs. The continuous efforts of the market players in the development of new drugs are anticipated to make a major contribution to the growth of the somatostatin analogue drug market across the globe.

The recent development in Market

In July 2019, Ipsen UK Ltd. had launched a new pre-filled syringe for Somatuline Autogel (lanreotide). The company has commercialized this syringe to be used on the NHS for the treatment of adult patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs), symptoms associated with neuroendocrine (particularly carcinoid) tumors (NETs), and acromegaly.

For More Information, get A full report of Somatostatin Analogue Drug Market is available at:

In June 2018, Novartis International AG had received US FDA approval for Novartis’ Signifor LAR (pasireotide) (a 2nd generation somatostatin analog (SSA)), for the treatment of patients with Cushing’s disease for whom pituitary surgery is not an option or has not been curative. In addition, Signifor LAR is approved to treat acromegaly patients who have had an inadequate response to the surgery and/or for whom surgery is not an option. The therapy will be available in 20 mg, 40 mg, and 60 mg doses and is administered intramuscularly once every four weeks

Global Somatostatin Analogue Drug Market Segmentation


Neuroendocrine Tumor (NET)

Global Somatostatin Analogue Drug Market – Segment by Region

North America

United States


Rest of Europe


Rest of the Asia-Pacific
Rest of the World

For more customized data, request for report customization @

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Somatostatin Analogue Drug Market Trends, Growth, Analysis and Forecast - 2025 here

News-ID: 2107389 • Views: 1019

More Releases from Orion Market Research

UK Electric Two-Wheeler Market 2023 Driving Factors Forecast Research 2029
UK electric two-wheeler market is estimated to grow at a considerable CAGR during the forecast period. UK Electric Two-Wheeler Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms to have constant observation of latest market trends which keep on changing. Constants shifts in the trends and key advancements
Asia-Pacific Electric Bus Market 2023 Driving Factors Forecast Research 2029
The Asia-Pacific electric bus market is estimated to grow at an exponential CAGR during the forecast period. Asia-Pacific Electric Bus Market report provides us with a complete outlook on thorough assessment of thorough data about vital feature of the global industry related to market size, revenue, development and market sales. This study report captures regulatory concerns and entry barriers that greatly affect the market growth. This report emphasizes on how
Canada Electric Bus Market 2023 Driving Factors Forecast Research 2029
Canada electric bus market is estimated to grow at a considerable CAGR during the forecast period. Canada Electric Bus Market research report allows making important decision making essential for business growth. It helps key participants further in applying right business ideas to grow business and choose the right business doing strategy. Having complete understanding of what purchasers are looking for in the market and which factors can influence their purchasing
China Electric Bus Market 2023 Driving Factors Forecast Research 2029
China electric bus market is estimated to grow at a significant CAGR during the forecast period. This informative China Electric Bus Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to

All 5 Releases

More Releases for Somatostatin

Somatostatin Analogs Market : 2020 the Year on a Positive Note
Zion Market Research analysts forecast the latest report on "Global Somatostatin Analogs Market Set for Rapid Growth, to reach Value around USD 8.38 Billion by 2025", according to their latest report the Somatostatin Analogs Market report covers the overall and all-inclusive analysis of the Somatostatin Analogs Market with all its factors that have an impact on market growth. The Somatostatin Analogs Market's complete outline is crystal clear penned down in
Global Somatostatin Sales Market Report 2018
This report studies the global Somatostatin market status and forecast, categorizes the global Somatostatin market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Free | Request Sample Copy of the Report @ Somatostatin is one kind of hormone. It is widely distributed throughout
Somatostatin Receptor Market For Hormonal Disorder, Oncology, Metabolic Disorder
MarketResearchReports.Biz adds “Global Somatostatin Receptor Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Somatostatin Receptor and the growth estimates for the forecasted period. This report studies the Somatostatin Receptor Type 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global
Global Somatostatin Market 2017 - UBPL, HYBIO, TianTaiShan, Shuangcheng, SAMARTH …
Apex Market Reports, recently published a detailed market research study focused on the "Somatostatin Market" across the global, regional and country level. The report provides 360° analysis of "Somatostatin Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Somatostatin industry, and estimates the future trend of Somatostatin market on the basis of
Global Somatostatin Market Research Reports - Industry Analysis 2017-2022
This Report Provides in depth survey of Somatostatin Market using various Market Research Analysis.It also provides the details about the major Key Players in the market based on the quality of the products,profiling and financial report of industry. Key Players in Global Market are: Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Somatostatin in these regions, from 2012 to 2022
Somatostatin Market Manufacturers, Region, Application and Forecast
MRC announces the addition of new study based research report on Somatostatin market to their suite of offerings. Where the Somatostatin market is heading? If you are involved in Somatostatin sector, the report brings to your attention a basic overview of the Somatostatin market with market definition, classification, applications, segmentation, plans, manufacturing processes, product specifications, cost structures, regional analysis, and value chain analysis. Equipped with all vital stats and information